IO Biotech Stock (NASDAQ: IOBT) stock price, news, charts, stock research, profile.
Open | $1.56 |
Close | $1.51 |
Volume / Avg. | 67.44K / 131.60K |
Day Range | 1.40 - 1.60 |
52 Wk Range | 0.82 - 2.18 |
Market Cap | $102.77M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 63 |
Short Interest | 0.38% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of IO Biotech (NASDAQ:IOBT) through any online brokerage.
Other companies in IO Biotech’s space includes: Anixa Biosciences (NASDAQ:ANIX), CytomX Therapeutics (NASDAQ:CTMX), Cellectar Biosciences (NASDAQ:CLRB), T2 Biosystems (NASDAQ:TTOO) and Armata Pharmaceuticals (AMEX:ARMP).
There is no analysis for IO Biotech.
IO Biotech has a consensus price target of $12.25.
The stock price for IO Biotech (NASDAQ: IOBT) is $1.56 last updated July 23, 2024 at 9:30 AM EDT.
There are no upcoming dividends for IO Biotech.
IO Biotech’s Q2 earnings are confirmed for Friday, August 9, 2024.
There is no upcoming split for IO Biotech.
IO Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.